[EN] HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE<br/>[FR] DERIVES D'HYDROXYETHYLAMINE UTILISES POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
申请人:GLAXO GROUP LTD
公开号:WO2004050619A1
公开(公告)日:2004-06-17
The present invention relates to novel hydroxyethylamine compounds of formula (I): (I) having Asp2 (-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated - amyloid levels or -amyloid deposits, particularly Alzheimer's disease.
Pd Catalysis on Dendronized Solid Support: Generation Effects and the Influence of the Backbone Structure
作者:Adi Dahan、Moshe Portnoy
DOI:10.1021/ja065265d
日期:2007.5.1
further decorated with phosphine ligands on the periphery and complexed with a Pd(0) catalytic precursor. The catalysis of the Heck and Suzuki reactions of bromobenzene with the first to third generation supported dendritic catalysts was examined and compared to that of the non-dendritic analogues. All of the examined reactions revealed a positive dendritic effect, reflected in up to 5-fold increase in yield
Preparation of novel polythioether dendrons on a solid supportElectronic supplementary information (ESI) available: procedures for the preparation of monomer 3, resins G1–G4, 4–8, and relevant characterisation data. See http://www.rsc.org/suppdata/cc/b3/b302324a/
作者:Adi Dahan、Avi Weissberg、Moshe Portnoy
DOI:10.1039/b302324a
日期:2003.4.30
A synthetic scheme for the solid-phase synthesis of unprecedented polythioether dendrons has been established, the dendrons prepared up to the fourth generation, and the applicability of the dendronized resins for supported catalysis has been demonstrated.
Hydroxyethylamine derivatives for the treatment of alzheimer's disease
申请人:Demont H Emmanuel
公开号:US20060025459A1
公开(公告)日:2006-02-02
The present invention relates to novel hydroxyethylamine compounds having Asp2 (β-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated β-amyloid levels or β-amyloid deposits, particularly Alzheimer's disease.
The present invention relates to novel hydroxyethylamine compounds having Asp2 (β-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated β-amyloid levels or β-amyloid deposits, particularly Alzheimer's disease.